In AF, higher concentrations of IL-6 have been associated with higher AF burden and increased mortality.8,21 This study confirms previous findings of the importance of IL-6 regarding the risk of CV death in AF and IL-6 together with GDF-15 signify inflammation as a substantial pathophysiologic process in AF and a possible therapeutic target.22 This evidence concerns the gene IL6 and atrial fibrillation.